Skip navigation

The anti-obesity potential of sigmoidin A

The anti-obesity potential of sigmoidin A

Habtemariam, Solomon (2012) The anti-obesity potential of sigmoidin A. Pharmaceutical Biology, 50 (12). pp. 1519-1522. ISSN 1388-0209 (Print), 1744-5116 (Online) (doi:https://doi.org/10.3109/13880209.2012.688838)

Full text not available from this repository.

Abstract

Context: During the last few decades, the prevalence of obesity in the western world has dramatically increased with epidemic proportions. Hand in hand with this statistic, the incidences of obesity-linked diseases such as diabetes are increasing with pandemic rate. The search for novel drugs and nutritional intervention approaches for obesity is now of significant importance.

Objective: The anti-obesity potential of eriodictyol (ERD) and its close structural analogue, sigmoidin A (SGN), were evaluated. SGN was isolated from Erythrina abyssinica Lam. ex DC. (Fabaceae).

Materials and methods: Concentrations between 300 and 0.1 µM of test samples and reference drugs made in three-fold dilutions were tested for enzyme inhibitory effects. The major obesity target, pancreatic lipase, was used to test the anti-obesity potential while the selective effects of the compounds were determined through assessments of effects on α-glucosidase.

Results: The inhibitory effect of SGN on pancreatic lipase (IC50, 4.5 ± 0.87 µM) was 30-times greater than that of ERD (IC50, 134 ± 19.39 µM) while their effect on α-glucosidase enzyme was comparable (IC50 value of 62.5 ± 9.47 and 57.5 ± 13.15 µM). The anti-obesity drug, orlistat, inhibited pancreatic lipase with an IC50 value of 0.3 ± 0.04 µM, while the anti-diabetic drug, acarbose, inhibited α-glucosidase with an IC50 value of 190.6 ± 16.05 µM.

Discussion: Although less active than the standard anti-obesity drug, orlistat, the observed activity indicated that prenylation of the flavonoid skeleton potently enhances anti-lipase activity.

Conclusion: Such groups of flavonoids need to be further investigated for their therapeutic and nutritional benefit in combating obesity problems.

Item Type: Article
Uncontrolled Keywords: Obesity, pancreatic lipase, α-glucosidase, eriodictyol, sigmoidin A, prenylated flavonoids, Erythrina abyssinica, Fabaceae Read More: http://informahealthcare.com/doi/abs/10.3109/13880209.2012.688838
Faculty / Department / Research Group: Faculty of Engineering & Science > School of Science (SCI)
Last Modified: 17 Oct 2016 09:13
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
Selected for GREAT 2019: None
Selected for REF2021: None
URI: http://gala.gre.ac.uk/id/eprint/13447

Actions (login required)

View Item View Item